Out-of-pocket costs continue to increase for patients who must buy commonly prescribed drugs to treat these five neurological ...

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) stock is trading higher on Monday after the company released new preclinical ...

The drug candidate was demonstrated to be well-tolerated and the pain and quality of life survey results suggested a potential for rapid improvement of peripheral neuropathy symptoms and post ...

The amount of money people pay out-of-pocket for branded drugs to treat neurological diseases like multiple sclerosis (MS), ...

Generic medications reduce the out-of-pocket (OOP) costs for common neurological conditions, apart from multiple sclerosis, ...

Alkem Laboratories partners with Sonnet BioTherapeutics to develop and commercialize SON-080, a potential treatment for diabetic peripheral neuropathy in India. The drug has shown promising nerve ...

The drug was well-tolerated, and the trial results suggested potential for rapid improvement in peripheral neuropathy symptoms and long-lasting effects compared to a placebo. Akhilesh Sharma ...

While a confirmed cure for neuropathy does not currently exist, numerous methods are accessible to control its symptoms. These include prescription drugs, physical therapy, and nutritional ...

SPONSORED – Neuropathy is becoming a bigger problem for more people than ever before. If you`re suffering from stabbing pain, ...

The amount of money people pay out-of-pocket for branded drugs to treat neurological diseases like multiple sclerosis (MS), Alzheimer's, and Parkinson's disease continues to rise, especially for MS ...